October 26, 2022 Dataset Open Access

Fraiman, Joseph; Erviti, Juan; Jones, Mark; Greenland, Sander; Whelan, Patrick; Kaplan, Robert; Doshi, Peter

MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nmm##2200000uu#4500</leader>
  <controlfield tag="005">20221026142626.0</controlfield>
  <controlfield tag="001">7251306</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Erviti, Juan</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Jones, Mark</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Greenland, Sander</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Whelan, Patrick</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Kaplan, Robert</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">University of Maryland School of Pharmacy</subfield>
    <subfield code="a">Doshi, Peter</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">388471</subfield>
    <subfield code="z">md5:94a91eb83538086542a2bac3a7ac627c</subfield>
    <subfield code="u">https://zenodo.org/record/7251306/files/Dataset - Final (20220721).xlsx</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">52780</subfield>
    <subfield code="z">md5:08ae27d292ccc181b1afa7481d7b8575</subfield>
    <subfield code="u">https://zenodo.org/record/7251306/files/Examples of AESI matching decision process.pdf</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">183622</subfield>
    <subfield code="z">md5:a9445ec680cade01bba02fb34dea7725</subfield>
    <subfield code="u">https://zenodo.org/record/7251306/files/Kaplan Greenland commentary Why We Question the Safety Profile of mRNA COVID-19 Vaccines.pdf</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">33627</subfield>
    <subfield code="z">md5:dad92234d257001c45cb0a1f123cb492</subfield>
    <subfield code="u">https://zenodo.org/record/7251306/files/Response from HealthFeedback.org (20221021).pdf</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">194517</subfield>
    <subfield code="z">md5:59fb275b6e4e7d30be6806b9f039e7e3</subfield>
    <subfield code="u">https://zenodo.org/record/7251306/files/Response to FDA critique (20220916).pdf</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">175648</subfield>
    <subfield code="z">md5:f35237af166a66cd97489c951e93c523</subfield>
    <subfield code="u">https://zenodo.org/record/7251306/files/Response to Full Fact (20220701) with Sept 2022 preamble.pdf</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">230941</subfield>
    <subfield code="z">md5:90e99dd47b1c53f3622017091b3029d9</subfield>
    <subfield code="u">https://zenodo.org/record/7251306/files/Response to Health Feedback 20221013 with preamble.pdf</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">29762</subfield>
    <subfield code="z">md5:3d6f4ab969103187e0dc68ab32b236dc</subfield>
    <subfield code="u">https://zenodo.org/record/7251306/files/Sensitivity analysis excluding SAEs requiring clinical judgments.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2022-10-26</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire_data</subfield>
    <subfield code="o">oai:zenodo.org:7251306</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Fraiman, Joseph</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Dataset and additional info for "Serious adverse events of special interest following mRNA vaccination in randomized trials" (Fraiman et al. 2022)</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;Dataset for:&lt;/p&gt;

&lt;p&gt;Fraiman J, Erviti J, Jones M, Greenland S, Whelan P, Kaplan RM, Doshi P. Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults. Vaccine. 2022 Aug 30;40(40):5798&amp;ndash;805. doi: 10.1016/j.vaccine.2022.08.036. Epub ahead of print. PMID: 36055877; PMCID: PMC9428332. &lt;a href="https://doi.org/10.1016/j.vaccine.2022.08.036"&gt;https://doi.org/10.1016/j.vaccine.2022.08.036&lt;/a&gt;&amp;nbsp;&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isSourceOf</subfield>
    <subfield code="a">10.1016/j.vaccine.2022.08.036</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.6564402</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.7251306</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">dataset</subfield>
  </datafield>
</record>